Last edition
News about Drug Discovery & Development
Roquette Unveils New LYCAGEL Flex Softgel Capsule Shell System
Roquette has developed its new LYCAGEL Flex hydroxypropyl pea starch premix for nutraceutical and pharmaceutical softgel capsules.
Drug Discovery & Development | 15/05/2024 | By Aishwarya | 445
Sartorius, Sanofi to Develop End-to-End Platform for Downstream Process Intensification
Sartorius has joined hands with Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing.
Drug Discovery & Development | 14/05/2024 | By Aishwarya | 913
Fulcrum Signs License Deal with Sanofi for Development of Losmapimod in FSHD
Fulcrum Therapeutics has entered into a collaboration and license agreement with Sanofi for the development and commercialization of losmapimod.
Drug Discovery & Development | 14/05/2024 | By Aishwarya | 403
The Jackson Laboratory and AbTherx to Boost Therapeutic Antibody Discovery
The Jackson Laboratory (JAX) has forged a strategic partnership with AbTherx to develop and commercialize cutting-edge tools to expedite antibody discovery and derisk the development of vital new therapies.
Drug Discovery & Development | 13/05/2024 | By Aishwarya | 608
Ribobay Pharma Offers oligo CRDMO Services with Cytiva FlexFactory Platform
Ribobay Pharma has announced that it will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva's first FlexFactory platform for oligo manufacturing.
Drug Discovery & Development | 13/05/2024 | By Aishwarya | 457
OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN)
The Vertex HFN offers an innovative approach to fracture fixation, aiming to enhance patient outcomes and streamline surgical procedures.
Drug Discovery & Development | 10/05/2024 | By Manvi | 484
Sanofi Signs Co-Exclusive Licensing Deal with Novavax to Co-Commercialize COVID-19 Vaccine
Sanofi has signed a co-exclusive licensing agreement with Novavax, a biotechnology company headquartered in Maryland, US.
Drug Discovery & Development | 10/05/2024 | By Aishwarya | 363
Zydus Completes Enrolment for EPICS IIITM Phase 2b/3 Trial of Saroglitazar Mg
Zydus Lifesciences has completed enrolment of Phase 2b/3 EPICS IIITM trial of Saroglitazar Mg in patients with Primary Biliary Cholangitis (PBC).
Drug Discovery & Development | 10/05/2024 | By Aishwarya | 560
The VCAS investigational study is a critical step towards demonstrating safety and performance of the FieldForce™ Ablation System, developed specifically to address the limitations of existing pulsed field ablation (PFA) and radiofrequency (RF) ablation systems, including a more time efficient treatment protocol for the treatment of ventricular arrhythm
Drug Discovery & Development | 09/05/2024 | By Manvi | 428
BioVersys Extends its Strategic Collaboration with GSK
BioVersys has extended its strategic collaboration with the global biopharma company GSK to accelerate the clinical development of alpibectir (BVL-GSK098) for the treatment of tuberculosis (TB).
Drug Discovery & Development | 09/05/2024 | By Aishwarya | 756
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy